Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,020,108 shares
Latest Disclosed Value $ 7,231,988
Morgan Stanley reports 48.75% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,020,108 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $5,686,604 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 3,941,377 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -48.75% during the quarter. The current value of the position is $4,929,064 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,020,108 -1,921,269 -48.75 7,232 -47.73 0.0004
2026-05-27 2025-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 3,941,377 294,338 8.07 13,834 16.36 0.0008
2026-02-13 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 3,941,377 294,338 13,834 0.0008
2026-05-27 2025-09-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 3,647,039 478,003 15.08 11,889 53.13 0.0007
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 3,647,039 478,003 11,889 0.0007
2025-08-15 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 3,169,036 527,144 19.95 7,764 -55.94 0.0005
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 2,641,892 1,457,183 123.00 17,621 18.33 0.0013
2025-05-15 2024-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 1,184,709 569,181 92.47 14,892 30.99 0.0010
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,184,709 569,181 14,892 0.0010
2025-05-14 2024-09-30 13F/A-2 ROCKET PHARMACEUTICALS COM 77313F106 615,528 139,540 29.32 11,369 10.93 0.0008
2025-02-14 2024-09-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 615,528 139,540 11,369 0.0008
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 615,528 139,540 11,369 0.0008
2025-05-14 2024-06-30 13F/A-2 ROCKET PHARMACEUTICALS COM 77313F106 475,988 -212,825 -30.90 10,248 -44.77 0.0008
2024-10-17 2024-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 475,988 -212,825 10,248 0.0008
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 475,988 -212,825 10,248 0.0008
2024-10-17 2024-03-31 13F/A-2 ROCKET PHARMACEUTICALS COM 77313F106 688,813 76,840 12.56 18,557 1.18 0.0015
2024-08-16 2024-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 688,813 76,840 18,557 0.0002
2024-05-15 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 688,813 76,840 18,557 0.0015
2024-08-16 2023-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 611,973 -166,778 -21.42 18,341 14.94 0.0016
2024-02-13 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 611,973 -166,778 18,341 0.0016
2023-11-15 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 778,751 276,627 55.09 15,957 59.93 0.0016
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 502,124 -89,902 -15.19 9,977 -1.62 0.0010
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 592,026 57,674 10.79 10,141 -3.02 0.0011
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 534,352 -661,733 -55.32 10,457 -45.22 0.0012
2022-11-14 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,196,085 -86,914 -6.77 19,089 8.13 0.0026
2022-10-27 2022-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 1,282,999 -203,689 -13.70 17,654 -25.13 0.0023
2022-08-15 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,282,999 -203,689 17,654 0.0023
2022-10-27 2022-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 1,486,688 286,807 23.90 23,578 -9.98 0.0032
2022-05-13 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,486,688 286,807 23,578 0.0032
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,199,881 1,036,981 636.58 26,193 437.95 0.0032
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 162,900 60,501 59.08 4,869 7.34 0.0007
2021-08-23 2021-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 102,399 -28,627 -21.85 4,536 -21.99 0.0006
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 102,399 -28,627 4,536 0.0001
2021-05-17 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 131,026 -84,987 -39.34 5,815 -50.91 0.0009
2021-02-16 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 216,013 -228,171 -51.37 11,845 16.64 0.0018
2020-11-13 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 444,184 -80,420 -15.33 10,155 -7.51 0.0020
2020-08-14 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 524,604 -235,839 -31.01 10,980 3.51 0.0024
2020-05-26 2020-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 760,443 -279,047 -26.84 10,608 -55.16 0.0029
2020-05-15 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 760,443 -279,047 10,608 814.9155
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,039,490 327,537 46.01 23,659 185.25 0.0055
2019-11-14 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 711,953 18,299 2.64 8,294 -20.30 0.0022
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 693,654 -108,081 -13.48 10,406 -26.00 0.0028
2019-05-15 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 801,735 258,931 47.70 14,062 74.84 0.0040
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 542,804 -165,371 -23.35 8,043 -53.87 0.0024
2019-04-23 2018-09-30 13F/A-2 ROCKET PHARMACEUTICALS COM 77313F106 708,175 540,942 323.47 17,435 431.07 0.0044
2018-11-20 2018-09-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 708,175 0 17,435 0.0044
2018-11-14 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 708,175 540,942 17,435
2019-04-23 2018-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 167,233 148,961 815.24 3,283 857.14 0.0009
2018-08-14 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 167,233 148,961 3,283
2019-04-23 2018-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 18,272 13,272 265.44 343 2,538.46 0.0001
2018-05-14 2018-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 18,272 343
2019-04-23 2017-12-31 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 5,000 -36,500 -87.95 13 -82.43 0.0000
2018-02-14 2017-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 5,000 -36,500 13
2017-11-14 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 41,500 -34,002 -45.03 74 -48.61 0.0000
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 75,502 8,070 11.97 144 6.67 0.0000
2017-05-22 2017-03-31 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 67,432 7,813 13.10 135 -62.81 0.0000
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 67,432 135
2017-02-22 2016-12-31 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 59,619 43,443 268.56 363 137.25 0.0001
2017-02-13 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 59,619 363
2016-11-10 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 16,176 5,299 48.72 153 88.89 0.0001
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 10,877 -68,776 -86.34 81 -86.27 0.0000
2016-05-12 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 79,653 64,755 434.66 590 249.11 0.0002
2016-02-09 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 14,898 8,783 143.63 169 196.49 0.0001
2016-02-08 2015-09-30 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 6,115 5,115 511.50 57 1,040.00 0.0000
2015-11-09 2015-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 6,115 57
2015-08-12 2015-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 1,000 -17,059 -94.46 5 -94.85 0.0000
2015-05-14 2015-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 18,059 18,059 97 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.